Clinical Trial Update: Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer [NA]

View source ↗

Summary

A clinical trial evaluating biomarkers from fine-needle aspiration in women at increased or normal risk of breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Breast Cancer | NA | Status: WITHDRAWN